Skip to main content

Table 1 Clinical and histopathological data

From: Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis

 

MS

IHC: Small cohort group

IHC: Large cohort group

IHC: Clinically difficult cases

PHC

DCC

PHC

DCC

PHC

DCC

PHC

DCC

N

10

8

12

12

72

74

5

2

Sex

 Male

5

5

8

10

38

55

5

1

 Female

5

3

4

2

34

19

0

1

Age

 Mean

64.5

70.1

65.4

73.4

63.1

68.6

70.2

63

 Range

48–79

60–76

50–82

63–79

27–82

47–83

65–76

52–74

Histology

 Well

0

4

1

2

8

12

1

0

 Moderate

10

4

9

6

61

55

4

1

 Poor

0

0

1

2

3

7

0

1

UICC Stage

 I

1

4

0

2

7

24

0

0

 II

8

4

9

9

52

48

5

1

 III

1

0

0

0

1

0

0

0

 IV

0

0

3

1

12

2

0

1

  1. MS Mass spectrometry, IHC Immunohistochemistry, PHC Pancreatic head cancer, DCC Distal cholangiocarcinoma, UICC Union for international cancer control